Newsfeeds - Spark Newswire

5 minute read

70 Biggest Movers From Friday

Today, 3:20 PM

Gainers Avadel Pharmaceuticals plc (NASDAQ: AVDL) shares climbed 133.6% to close at $2.50 on Friday. Avadel Pharmaceuticals shares dipped 68% on Thursday after announcing new FDA request for experimental narcolepsy drug.

ACB

4 minute read

As COVID Subsidies, Here Are 8 Infectious Diseases That Could Emerge As Potent Threats

By Shanthi Rexaline

Today, 3:20 PM

The COVID-19 pandemic that emerged in early 2020 doesn't seem to have run its course. Daily average cases, though have declined notably, stood at 110,084 in the U.S. as of Thursday, according to data provided by New York Times.

IBB

2 minute read

Movers

12 Health Care Stocks Moving In Friday’s Intraday Session

By Benzinga Insights

Today, 3:20 PM

Gainers

ALLR

3 minute read

41 Stocks Moving In Friday’s Mid-Day Session

By Lisa Levin

Today, 3:20 PM

Gainers Avadel Pharmaceuticals plc (NASDAQ: AVDL) shares rose 60.2% to $1.7136. Avadel Pharmaceuticals shares dipped 68% on Thursday after announcing new FDA request for experimental narcolepsy drug.

ACB

1 minute read

Italian Health Minister Says Monkeypox Cases Have Risen To 12

By Benzinga Newsdesk

Today, 3:20 PM

-Reuters

AEMD

1 minute read

FDA
News

Abbott Laboratories Says Is Actively Developing A PCR Test For Monkeypox; PCR Test For Monkeypox Will Be Provided To Global Partners Of Co’s Pandemic Defense Coalition

By Benzinga Newsdesk

Today, 3:20 PM

PCR Test For Monkeypox Will Be Provided To Global Partners Of Co's Pandemic Defense Coalition To Aid In Identification Of Virus Locally

ABT

1 minute read

News

New York City Identifies One Presumptive Case Of Monkeypox Virus

By Benzinga Newsdesk

Today, 3:20 PM

-Reuters

AEMD

3 minute read

Pharma Firm SIGA Cashes In On Monkeypox Scare

Today, 3:20 PM

New York-based pharmaceutical firm SIGA Technologies (NASDAQ: SIGA) is among the companies to benefit from the growing threat of monkeypox, recently pushing its shares to an almost decade-high after the company obtained approval in Europe to use its TPOXX antiviral drug for the treatment of monkeypox.

MRNA